Ann Dermatol.  2015 Jun;27(3):347-348. 10.5021/ad.2015.27.3.347.

A Case of Psoriasis Accompanied by Systemic Lupus Erythematosus

• Kim EJ
• Park HS
• Yoon HS
• Cho S

• KMID: 2352517
• DOI: http://doi.org/10.5021/ad.2015.27.3.347

Abstract

No abstract available.

MeSH Terms

Lupus Erythematosus, Systemic*
Psoriasis*

Figure

• 

  Fig. 1 (A) Erythematous scaly patches on the forehead. (B) An erythematous scaly patch on the inguinal area. (C) Regular elongation of rete ridges, parakeratosis, and mononuclear cell infiltration in the epidermis (H&E, ×40; inset: ×100).

• 

  Fig. 2 (A) Swollen proximal interphalangeal joints on bilateral third fingers. (B) Radiograph showing marginal erosion at the right third proximal interphalangeal joint, small bony proliferation at the right index metacarpophalangeal joint, and suspicious erosion at the left middle proximal interphalangeal joint.

Reference

1. Guidelli GM, Fioravanti A, Rubegni P, Feci L. Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature. Rheumatol Int. 2013; 33:2927–2930.

2. Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, et al. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology (Oxford). 2009; 48:1451–1454.

3. Murdaca G, Colombo BM, Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med. 2011; 6:487–495.

4. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012; 181:8–18.

5. Nalbandian A, Crispín JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009; 157:209–215.